Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial

相似書籍

• Maintenance DFMO Increases Survival in High Risk Neuroblastoma
  由: Sholler, Giselle L. Saulnier, et al.
  出版: (2018)
• Maintenance DFMO Increases Survival in High Risk Neuroblastoma
  由: Giselle L. Saulnier Sholler, et al.
  出版: (2018)
• Polyamine Inhibition with DFMO: Shifting the Paradigm in Neuroblastoma Therapy
  由: Joseph Schramm, et al.
  出版: (2025)
• A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma
  由: Villablanca, Judith G., et al.
  出版: (2016)
• A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma
  由: Judith G. Villablanca, et al.
  出版: (2016)